Pyrotinib in Combination With Trastuzumab in Treatment-refractory, HER2-positive Metastatic Colorectal Cancar.

Condition:   Colorectal Cancer Intervention:   Drug: Pyrotinib Sponsor:   Shanghai Changzheng Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials